News
MRK
135.84
+0.21%
0.29
Wall Street Week Ahead
Seeking Alpha · 18h ago
Notable trades: Netflix, Coca-Cola, Pfizer among notable names
Seeking Alpha · 1d ago
Energy Transfer, Merck, Lockheed, CoreWeave, Twilio Insider Shock
TipRanks · 1d ago
How To Invest $100,000 In A Retiree's SWAN Income Portfolio
Seeking Alpha · 1d ago
Merck (MRK) Could Be 1% Undervalued On Raised Guidance And KEYTRUDA News
Simply Wall St · 2d ago
Merck & Company (MRK) Gets a Buy from Barclays
TipRanks · 2d ago
QUICK SPARK: Dell, JPMorgan, Merck All Mark New All-Time Highs
Benzinga · 3d ago
Immunome: Maintaining My 'Strong Buy' Rating With 2 Catalysts On The Horizon
Seeking Alpha · 3d ago
Roche Is Getting More Benefit Of The Doubt On Improving Execution
Seeking Alpha · 3d ago
Pharma companies sour on Swiss drug applications amid Trump’s MFN policy
Seeking Alpha · 3d ago
Will Higher 2026 Guidance and New Approvals Shift Merck's (MRK) KEYTRUDA-Heavy Narrative?
Simply Wall St · 3d ago
Notable ETF Inflow Detected - XLV, UNH, MRK, AMGN
NASDAQ · 3d ago
Merck on Track for Record High Close -- Data Talk
Dow Jones · 3d ago
Splitting the MMR vaccine? Experts warn it could take a decade
Seeking Alpha · 3d ago
Big Pharma's Future Growth Rests on Chinese Science? Expert Says: 'We Can't Ban Our Way Out of This'
Benzinga · 4d ago
Merck Price Target Raised to $143.00/Share From $120.00 by Daiwa Capital
Dow Jones · 4d ago
Merck Raised to Outperform From Neutral by Daiwa Capital
Dow Jones · 4d ago
Daiwa Capital Upgrades Merck & Co to Outperform, Raises Price Target to $143
Benzinga · 4d ago
Merck On Pace for Record High Close -- Data Talk
Dow Jones · 4d ago
23 dividend safety stocks beating the S&P 500 this year
Seeking Alpha · 4d ago
More
Webull provides a variety of real-time MRK stock news. You can receive the latest news about Merck & Co through multiple platforms. This information may help you make smarter investment decisions.
About MRK
Merck & Co., Inc. is a global health care company that delivers health solutions through its prescription medicines, including biologic therapies, vaccines and animal health products. Its Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Company sells its human health pharmaceutical products primarily to drug wholesalers and retailers, hospitals, government agencies and managed health care providers. It sells these human health vaccines primarily to physicians, wholesalers, distributors and government entities. Its Animal Health segment discovers, develops, manufactures and markets a range of veterinary pharmaceutical and vaccine products, as well as health management solutions and services, for the prevention, treatment and control of disease in all livestock and companion animal species. Its products include KEYTRUDA (pembrolizumab) injection, for intravenous use; WELIREG (belzutifan) tablets, for oral use; Ohtuvayre (ensifentrine) and others.